Smarter Diagnostics: Turning Lab Testing into a Strategic Advantage for Value-Based Care with Dr. Julie Schulz, Vice President of Product at Avalon Healthcare Solutions

This podcast is brought to you by Outcomes Rocket, your exclusive healthcare marketing agency. Learn how to accelerate your growth by going to⁠ outcomesrocket.com Diagnostic intelligence is transforming healthcare by turning lab testing from a cost center into a strategic asset.  In this episode, Dr. Julie Schulz, Vice President of Product at Avalon Healthcare Solutions, discusses how integrating diagnostics into value-based care can lead to improved quality, lower costs, and enhanced preventive medicine. She notes that physicians are overwhelmed by the rapid growth of genetic testing and evolving clinical guidelines, leading to cognitive overload and inefficiencies. Diagnostic intelligence, she explains, can alleviate this by identifying the right tests at the right time and automating prior authorizations, reducing treatment timelines from 60 days to just 15. Dr. Schulz emphasizes that diagnostics inform 70% of healthcare decisions, making their effective use vital for improving access and outcomes, particularly among underserved populations, and underscores that simplifying data and embedding clinical decision support earlier can benefit both patients and providers. Tune in and learn how diagnostic intelligence is shaping the future of precision medicine and preventive care! Resources Connect with and follow Dr. Julie Schulz on LinkedIn. Follow Avalon Healthcare Solutions on LinkedIn and explore their website. Read Avalon Healthcare Solutions’ Annual Lab Trend Report here.